- Report
- September 2023
- 182 Pages
Global
From €3867EUR$4,000USD£3,324GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2022
- 174 Pages
Global
From €3867EUR$4,000USD£3,324GBP
- Report
- October 2021
- 139 Pages
Global
From €3867EUR$4,000USD£3,324GBP
Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease. Disease markers are a type of biomarker that can be used to diagnose, monitor, and predict the progression of a disease. Disease markers can be used to identify the presence of a disease, measure the severity of a disease, and predict the risk of developing a disease. Disease markers can be found in a variety of biological samples, including blood, urine, saliva, and tissue.
Disease markers are used in a variety of medical applications, including diagnostics, prognostics, and drug development. They can be used to identify the presence of a disease, measure the severity of a disease, and predict the risk of developing a disease. Disease markers can also be used to monitor the effectiveness of treatments and to identify potential drug targets.
The disease marker market is a rapidly growing sector of the biomarker market. Companies in this market are focused on developing and commercializing disease markers for a variety of medical applications. Examples of companies in this market include Bio-Rad Laboratories, Illumina, Qiagen, and Thermo Fisher Scientific. Show Less Read more